ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft failure"

  • 2018 American Transplant Congress

    Predictors of Early Graft Loss in Older Kidney Transplant Recipients

    P. Amaechi, R. Rodriguez, V. Rao, D. Taber, M. Posadas Salas.

    Medical University of South Carolina, Charleston, SC.

    Older kidney transplant recipients are vulnerable to early graft loss likely due to frailty and burden of comorbidities. Other factors not inherent to the recipient…
  • 2018 American Transplant Congress

    Analysis of Cost Effectiveness of Treatment for Acute Antibody-Mediated Rejection

    C. McDermott, K. Carsky, P. Ferrin, A. Gaines, D. Chernobylsky, M. Killackey, A. Paramesh, R. Zhang, J. Buell.

    Tulane University School of Medicine, New Orleans, LA.

    Purpose: Because AMR can be a risk factor for graft loss, the expense created by AMR treatment may be subject to scrutiny in patients who…
  • 2018 American Transplant Congress

    Urinary Sulfate Excretion and Late Graft Failure in Renal Transplant Recipients

    M. Said,1 A. Post,1 I. Minovic,1 M. van Londen,1 H. van Goor,2 D. Postmus,3 M. Heiner-Fokkema,4 E. van den Berg,1 A. Pasch,5 G. Navis,1 S. Bakker.1

    1Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands; 2Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands; 3Department of Epidemiology, University of Groningen, Groningen, Netherlands; 4Department of Laboratory Medicine, University Medical Center Groningen, Groningen, Netherlands; 5Department of Biomedical Research, University of Bern, Bern, Switzerland.

    BackgroundHydrogen sulfide (H2S), produced from the metabolism of dietary sulfur-containing amino acids, is allegedly a potential renoprotective compound. High 24h urinary excretion of pathway intermediate…
  • 2018 American Transplant Congress

    Redo Kidney Transplant in FSGS

    J. Verbesey, A. Javaid, S. Yi, G. Vranic, A. Gilbert, P. Abrams, S. Ghasemian, J. Moore, B. Thomas, M. Cooper, B. Javaid.

    Kidney and Pancreas Transplant Program, MedStar Georgetown Transplant Institute, Washington, DC.

    Objective: Analyze risk of graft failure due to recurrent FSGS in patients with prior failed kidney transplants under consideration for a subsequent transplant.Results: We identified…
  • 2018 American Transplant Congress

    Two Trajectories of Post-DSA eGFR after Kidney Transplant

    J. Beaumont,1 K. Briley,2 A. Maldonado,3 C. Haisch,2 P. Bolin,2 S. Kendrick,4 H. Jones,4 K. McLawhorn,4 D. Leeser,2 L. Rebellato,2 M. Everly.1

    1Terasaki Research Institute, Los Angeles, CA; 2East Carolina University, Greenville, NC; 3Vidant Medical Center, Greenville, NC; 4Eastern Nephrology Associates, Greenville, NC.

    A clearer understanding of the patterns of glomerular filtration rate (GFR) decline following donor-specific antibody (DSA) development and the factors that might be associated with…
  • 2018 American Transplant Congress

    Impact of a Steroid Free Immunosuppressive Regimen on Patient and Graft Outcomes in Pancreas Transplant Recipients

    M. Cote,1 C. Rogers,1 K. Khwaja,2 A. Evenson,2 M. Pavlakis,2 K. Richards.1

    1Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA; 2Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA.

    Steroids have been an important component of maintenance immunosuppression in solid organ transplant, but their adverse effect profile has led to the development of steroid…
  • 2018 American Transplant Congress

    Hospital Readmission Patterns in the First Year after Kidney Transplantation: A Twelve-Year, Single-Center Experience

    M. Nguyen, C. Avila, J. Benedict, A. El-Hinnawi, A. Rajab, R. Pelletier, M. Henry, G. Bumgardner.

    Transplant Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.

    Purpose: The majority of studies examining hospital readmissions (HR) after kidney transplantation (KT) focus on 30-day HR rates using multi-institutional data with non-uniform clinical protocols.…
  • 2018 American Transplant Congress

    Long-Term Outcomes of Primary Kidney Transplant from Expanded Criteria Maastricht Category 3 DCD Donors: A Single-Centre Observational Study

    E. Favi,1 C. Puliatti,2 S. Iesari,3 M. Ferraresso,1 R. Cacciola.2

    1Kidney Transplantation, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy; 2Kidney Transplantation, The Royal London Hospital, London, United Kingdom; 3Kidney Transplantation, University of L'Aquila, L'Aquila, Italy.

    Background. Kidney transplants (KTx) from standard (STD) DCD donors have higher rates of primary non function (PNF) and delayed graft function (DGF) than DBD but…
  • 2018 American Transplant Congress

    Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry

    S. Sanoff,1 K. Ravindra,1 W. Irish.1,2

    1Duke University Medical Center, Durham, NC; 2CTI Consulting, Raleigh, NC.

    Introduction:Belatacept (BEL) was FDA approved for Kidney Transplantation (KTx) June 2011. It has largely been evaluated in two controlled trials (N Engl J Med 2016;374:333-43).…
  • 2018 American Transplant Congress

    Outcome of Second Kidney Transplantation According to Previous Pediatric Donor Type: A Retrospective Cohort Analysis

    K. Phonphok, T. Duong, S. Panombualert, S. Bunnapradist.

    Medicine-Nephrology, UCLA, Los Angeles, CA.

    Background: With the prioritization of age ≤ 18 years old at the time of registration on the kidney transplant waiting list in the United States,…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences